Profile data is unavailable for this security.
About the company
Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, the Omnipod Insulin Management System, and Omnipod GO. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen's Neulasta. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. Omnipod 5 includes an AID algorithm embedded in the Pod.
- Revenue in USD (TTM)1.70bn
- Net income in USD206.30m
- Incorporated2000
- Employees3.00k
- LocationInsulet Corp100 Nagog ParkACTON 01720-3440United StatesUSA
- Phone+1 (978) 600-7000
- Fax+1 (978) 600-0120
- Websitehttps://www.omnipod.com
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
DENTSPLY SIRONA Inc | 3.97bn | -132.00m | 6.30bn | 15.00k | -- | 1.91 | 29.86 | 1.59 | -0.6217 | -0.6217 | 18.67 | 15.89 | 0.5282 | 3.00 | 5.98 | 264,333.30 | -1.76 | -1.14 | -2.13 | -1.32 | 52.71 | 53.65 | -3.33 | -2.51 | 0.9467 | 3.63 | 0.3914 | -- | 1.10 | -0.1071 | 86.11 | -- | -4.54 | 9.86 |
Globus Medical Inc | 1.57bn | 122.87m | 6.82bn | 5.00k | 43.22 | 1.72 | 25.39 | 4.35 | 1.17 | 1.17 | 13.72 | 29.32 | 0.438 | 0.9557 | 4.38 | 313,695.20 | 3.43 | 6.90 | 3.72 | 7.45 | 65.05 | 71.73 | 7.83 | 14.05 | 2.72 | -- | 0.0947 | 0.00 | 53.34 | 17.08 | -35.39 | -4.72 | 5.57 | -- |
Inspire Medical Systems Inc | 624.80m | -21.15m | 7.00bn | 1.01k | -- | 11.93 | -- | 11.20 | -0.7298 | -0.7298 | 21.32 | 19.37 | 1.01 | 4.22 | 8.27 | 618,001.00 | -3.41 | -11.27 | -3.84 | -12.60 | 84.54 | 84.47 | -3.39 | -13.57 | 7.17 | -- | 0.00 | -- | 53.19 | 65.32 | 52.87 | -- | 148.37 | -- |
Masimo Corp | 2.05bn | 81.50m | 7.16bn | 3.80k | 89.75 | 5.23 | 39.82 | 3.49 | 1.51 | 1.51 | 37.84 | 25.85 | 0.6552 | 2.00 | 5.04 | 538,973.70 | 2.61 | 8.65 | 3.22 | 10.31 | 49.00 | 57.30 | 3.98 | 12.03 | 1.22 | 3.43 | 0.399 | 0.00 | 0.6042 | 19.00 | -43.21 | -15.96 | 31.06 | -- |
MSA Safety Inc | 1.79bn | 58.52m | 7.42bn | 5.10k | 131.76 | 7.70 | 62.19 | 4.15 | 1.43 | 1.43 | 45.21 | 24.59 | 0.7863 | 2.97 | 6.04 | 350,518.80 | 2.58 | 5.08 | 3.03 | 6.00 | 47.67 | 45.21 | 3.28 | 7.02 | 1.48 | 6.07 | 0.3836 | 65.91 | 17.00 | 5.65 | -67.41 | -13.66 | 4.72 | -1.10 |
Penumbra Inc | 1.06bn | 90.95m | 7.95bn | 4.20k | 88.70 | 6.74 | 67.28 | 7.51 | 2.32 | 2.32 | 27.00 | 30.48 | 0.7232 | 1.04 | 5.23 | 252,029.00 | 6.21 | 2.32 | 6.91 | 2.61 | 64.49 | 63.90 | 8.59 | 3.17 | 3.49 | -- | 0.0215 | 0.00 | 24.95 | 18.93 | 4,643.16 | 68.60 | 9.64 | -- |
Stevanato Group SpA | 1.16bn | 156.25m | 8.31bn | 5.64k | 46.70 | 6.00 | 34.54 | 7.13 | 0.5893 | 0.5893 | 4.39 | 4.59 | 0.5818 | 3.14 | 2.75 | 206,651.40 | 7.81 | -- | 10.81 | -- | 32.28 | -- | 13.42 | -- | 1.06 | 19.74 | 0.2593 | -- | 10.34 | -- | 1.95 | -- | -- | -- |
Henry Schein, Inc. | 12.34bn | 416.00m | 9.36bn | 25.00k | 23.11 | 2.58 | 13.96 | 0.7583 | 3.15 | 3.15 | 93.67 | 28.28 | 1.29 | 4.49 | 7.47 | 493,560.00 | 4.40 | 6.09 | 7.31 | 10.44 | 31.29 | 30.04 | 3.42 | 4.40 | 0.9963 | 10.63 | 0.3133 | 0.00 | -2.44 | 5.55 | -22.68 | -0.1456 | 21.27 | -- |
Teleflex Inc | 2.97bn | 357.57m | 9.74bn | 14.50k | 27.35 | 2.19 | 16.24 | 3.27 | 7.56 | 7.53 | 62.88 | 94.41 | 0.4114 | 2.20 | 6.98 | 205,137.20 | 4.95 | 5.86 | 5.39 | 6.42 | 55.37 | 55.04 | 12.02 | 14.62 | 1.29 | 7.78 | 0.2901 | 15.84 | 6.57 | 3.97 | -1.47 | 12.73 | 2.51 | 0.00 |
Insulet Corp | 1.70bn | 206.30m | 11.50bn | 3.00k | 58.26 | 15.66 | 41.19 | 6.77 | 2.82 | 2.82 | 22.78 | 10.48 | 0.7014 | 1.43 | 6.00 | 565,700.00 | 8.53 | 2.71 | 10.26 | 3.14 | 68.35 | 65.81 | 12.16 | 4.28 | 2.62 | 40.74 | 0.659 | 0.00 | 30.02 | 24.66 | 4,384.78 | 128.77 | -7.63 | -- |
Shockwave Medical Inc | 730.23m | 147.28m | 12.34bn | 1.47k | 85.26 | 18.20 | 78.28 | 16.90 | 3.86 | 3.86 | 19.13 | 18.08 | 0.66 | 1.04 | 7.86 | 497,431.90 | 13.31 | 10.29 | 14.40 | 11.39 | 86.94 | 84.69 | 20.17 | 15.14 | 10.73 | 19.70 | 0.5226 | 0.00 | 49.11 | 126.45 | -31.81 | -- | 72.88 | -- |
Holder | Shares | % Held |
---|---|---|
Capital Research & Management Co. (Global Investors)as of 31 Dec 2023 | 9.48m | 13.55% |
The Vanguard Group, Inc.as of 31 Dec 2023 | 7.73m | 11.06% |
Fidelity Management & Research Co. LLCas of 31 Dec 2023 | 5.52m | 7.89% |
BlackRock Fund Advisorsas of 31 Dec 2023 | 4.10m | 5.87% |
Wellington Management Co. LLPas of 31 Dec 2023 | 3.25m | 4.64% |
SSgA Funds Management, Inc.as of 31 Dec 2023 | 2.88m | 4.13% |
Capital Research & Management Co. (World Investors)as of 31 Dec 2023 | 2.21m | 3.16% |
Geode Capital Management LLCas of 31 Dec 2023 | 1.61m | 2.30% |
ClearBridge Investments LLCas of 31 Dec 2023 | 1.33m | 1.90% |
Citadel Advisors LLCas of 31 Dec 2023 | 1.31m | 1.87% |